MongoDB (MDB) Shares Up 12% Following Strong Q2 Beat

Go back to MongoDB (MDB) Shares Up 12% Following Strong Q2 Beat

MongoDB (MDB) PT Raised to $534 at Needham & Company

September 3, 2021 7:07 AM EDT

Needham & Company analyst Jack Andrews raised the price target on MongoDB (NASDAQ: MDB) to $534.00 (from $415.00) while maintaining a Buy rating.

The analyst commented, "MDB reported very strong 2QFY22 results as revenue was well ahead of consensus and the mid-point of FY22 guidance was raised... More

MongoDB (MDB) Soars on Narrower Q2 Loss, Firms Raise PTs on Accelerating Sales and Atlas Growth

September 3, 2021 7:00 AM EDT

Shares of MongoDB (NASDAQ: MDB) are trading 13.4% higher in pre-open Friday after the software company smashed analyst estimates for Q2.

MongoDB reported a loss of $0.24 per share, narrower than a loss of $0.39 expected from analysts. Sales for the quarter came in at $198.7 million versus the consensus estimate of $184.2 million.

"MongoDB's second quarter results were exceptionally strong across the board, highlighted by Atlas revenue growth of 83%. Our performance reflects the desire of nearly every business to use a modern application data platform that enables them to accelerate the pace of their digital innovation... More

MongoDB (MDB) PT Raised to $410 at Mizuho Securities

September 3, 2021 6:20 AM EDT

Mizuho Securities analyst Matthew Broome raised the price target on MongoDB (NASDAQ: MDB) to $410.00 (from $350.00) while maintaining a Neutral rating following earnings.

The analyst commented, "MDB reported very strong F2Q earnings yesterday after the close, comfortably beating our (and the Street's) revenue... More

MongoDB (MDB) Tops Q2 EPS by 15c

September 2, 2021 4:08 PM EDT

MongoDB (NASDAQ: MDB) reported Q2 EPS of ($0.24), $0.15 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $198.7 million versus the consensus estimate of $184.2 million.

GUIDANCE:

MongoDB sees Q3 2022 EPS of ($0.42)-($0.39), versus the consensus of ($0.37). MongoDB sees Q3... More